| Name | Title | Contact Details |
|---|
FifthWall Solutions is a top-rated cyber insurance partner that works with 1,500+ MSPs and their clients, accessing 45+ carriers to offer the best rates and coverage options. FifthWall also educates and equips MSPs to navigate the cyber insurance process for their clients and leverage their stack along the way. Interested in partnering with FifthWall Solutions? Message us at info@fifthwallsolutions.com or call us at 844.719.0981.
Mitsubishi Polyester Film is a leading supplier of polyester (PET) film, part of Mitsubishi Chemical America, Inc. The company operates manufacturing sites in the USA, Europe, Japan, Indonesia, and China, with a total global capacity of 250,000 tons. It specializes in biaxially oriented polyester (boPET) films, offering a range of thicknesses and polymer types for various applications. Key brands include Hostaphan® and Diafoil®. The company emphasizes vertical integration, with on-site PET resin manufacturing and over 50 coating types. It also focuses on sustainability through initiatives like the REPROCESS™ recycling program, which incorporates post-industrial recycled content. Mitsubishi Polyester Film provides customized solutions through its global R&D efforts, addressing product design, manufacturing, logistics, and process challenges.
Tech Observer is a global Contract Research Organization (CRO) founded in 2005, with its headquarters in Paramus, New Jersey, and additional offices in New Delhi, Mumbai, and Singapore. The company specializes in clinical development support for the pharmaceutical, biotechnology, and medical device industries, extending its reach through local partners across the Asia-Pacific region. The company offers a comprehensive range of services that encompass the entire clinical research process. These include managing clinical trials, clinical data management, biostatistics and SAS programming, medical writing, post-marketing clinical studies, and staffing services. Tech Observer is ISO 9001:2008 and ISO 14155:2011 certified, demonstrating its commitment to quality and regulatory compliance. With a workforce of around 400 professionals, the company serves over 50 clients in more than 30 countries, focusing on various therapeutic areas such as oncology, cardiology, and infectious diseases. Tech Observer also emphasizes innovation with solutions like its AI-driven clinical trial risk tool, MyRBQM, and promotes diversity and professional growth within its team.